Clincosm LogoSign in Get a demo

benign prostatic hyperplasia (bph)

Showing 26 - 46 of 46
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostatic Hyperplasia, Benign Prostatic Hyperplasia (BPH), Prostatism Trial in Charlottesville (Embozene Microspheres)

Unknown status
  • Prostatic Hyperplasia
  • +7 more
  • Embozene Microspheres
  • Charlottesville, Virginia
    University of Virginia Health Systems
Apr 15, 2019

Ischaemic Heart Disease (IHD), Benign Prostatic Hyperplasia (BPH), Lower Urinary Tract Symptoms (LUTS) Trial (Tamsulosin Oral

Completed
  • Ischaemic Heart Disease (IHD)
  • +2 more
  • Tamsulosin Oral Capsule
  • TURP
  • (no location specified)
Feb 25, 2019

Benign Prostatic Hyperplasia (BPH) Trial (UroLift System procedure)

Completed
Has Results
  • Benign Prostatic Hyperplasia (BPH)
  • UroLift System procedure
  • (no location specified)
Feb 5, 2019

Benign Prostatic Hyperplasia (BPH) Trial in Limoges, Paris, Toulouse (AQUABEAM System)

Completed
  • Benign Prostatic Hyperplasia (BPH)
  • AQUABEAM System
  • Limoges, France
  • +2 more
Feb 20, 2019

Benign Prostatic Hyperplasia (BPH) Trial in Bari (aquablation, holep, pvp)

Unknown status
  • Benign Prostatic Hyperplasia (BPH)
  • aquablation
  • +2 more
  • Bari, Italy
    University of Bari "Aldo Moro"
Feb 18, 2019

Benign Prostatic Hyperplasia (BPH) Trial in Ann Arbor, Toledo (Vortx Rx - Histotripsy BPH Device)

Terminated
  • Benign Prostatic Hyperplasia (BPH)
  • Vortx Rx - Histotripsy BPH Device
  • Ann Arbor, Michigan
  • +1 more
Jun 6, 2018

Benign Prostatic Hyperplasia (BPH) Trial in Brooklyn (Greenlight XPS Laser, BiVAP Saline Vaporization of the prostate)

Completed
Has Results
  • Benign Prostatic Hyperplasia (BPH)
  • Greenlight XPS Laser
  • BiVAP Saline Vaporization of the prostate
  • Brooklyn, New York
    Brooklyn Urology Research Group
Apr 13, 2018

Benign Prostatic Hyperplasia (BPH) Trial in United States (NX-1207, Placebo)

Completed
  • Benign Prostatic Hyperplasia (BPH)
  • Laguna Hills, California
  • +34 more
Mar 9, 2017

Benign Prostatic Hyperplasia (BPH) Trial in Worldwide (Permixon® 160 mg, Tamsulosine LP, Placebo matching Permixon® 160 mg)

Completed
  • Benign Prostatic Hyperplasia (BPH)
  • Permixon® 160 mg
  • +3 more
  • Benesov, Czech Republic
  • +57 more
Sep 1, 2016

Lower Urinary Tract Symptoms, Overactive Bladder, Benign Prostatic Hyperplasia (BPH) Trial in Taipei (Tamsulosin, Solifenacin)

Completed
  • Lower Urinary Tract Symptoms
  • +2 more
  • Taipei, Taiwan
    Site
Mar 17, 2016

Using the Expired Breath Ethanol Test

Completed
  • Benign Prostatic Hyperplasia (BPH)
    • St. Gallen, Switzerland
      Cantonal Hospital St. Gallen
    Feb 1, 2016

    Benign Prostatic Hyperplasia (BPH) Trial (Vortx Rx - Histotripsy BPH Device)

    Withdrawn
    • Benign Prostatic Hyperplasia (BPH)
    • Vortx Rx - Histotripsy BPH Device
    • (no location specified)
    Aug 17, 2015

    Benign Prostatic Hyperplasia (BPH) Trial in Newburgh (Tolterodine ER 4mg, Placebo, Pre-randomization Dutasteride)

    Completed
    Has Results
    • Benign Prostatic Hyperplasia (BPH)
    • Tolterodine ER 4mg
    • +2 more
    • Newburgh, Indiana
      Deaconess Clinic Gateway Health Center
    Apr 15, 2015

    Benign Prostatic Hyperplasia (BPH) Trial in Worldwide (Permixon® 160 mg, Tamsulosine Arrow LP, Placebo matching Permixon® 160

    Completed
    • Benign Prostatic Hyperplasia (BPH)
    • Permixon® 160 mg
    • +3 more
    • Angers, France
    • +31 more
    Jan 14, 2014

    Benign Prostatic Hyperplasia (BPH) Trial in Beijing (needle)

    Completed
    Has Results
    • Benign Prostatic Hyperplasia (BPH)
    • needle
    • Beijing, China
      Guang'an Men Hospotal Affiliated to China Academy of Chinese Med
    May 18, 2013

    Benign Prostatic Hyperplasia (BPH) Trial in Seoul (In combination of 0.2mg finasteride and 5mg tamsulosin, GL2701 capsule)

    Completed
    • Benign Prostatic Hyperplasia (BPH)
    • In combination of 0.2mg finasteride and 5mg tamsulosin
    • GL2701 capsule
    • Seoul, Korea, Republic of
      Clinical trial center of Anam Hospital
    Apr 8, 2013

    Benign Prostatic Hyperplasia (BPH), Enlarged Prostate Trial in United States (2.5 mg NX-1207, 0.125 mg NX-1207, finasteride)

    Completed
    • Benign Prostatic Hyperplasia (BPH)
    • Enlarged Prostate
    • 2.5 mg NX-1207
    • +2 more
    • Huntsville, Alabama
    • +29 more
    Jun 12, 2012

    Benign Prostatic Hyperplasia (BPH), Benign Prostatic Enlargement (BPE) Trial in Rome (BOTOX)

    Completed
    • Benign Prostatic Hyperplasia (BPH)
    • Benign Prostatic Enlargement (BPE)
    • Rome, Italy
      Catholic University of Sacred Heart
    Mar 27, 2012

    Benign Prostatic Hyperplasia (BPH) Trial in Worldwide (Tadalafil 5 mg, Placebo tablet, Tamsulosin)

    Completed
    Has Results
    • Benign Prostatic Hyperplasia (BPH)
    • Tadalafil 5 mg
    • +3 more
    • Adelaide, South Australia, Australia
    • +43 more
    Mar 8, 2012

    Benign Prostatic Hyperplasia (BPH) Trial in United States (Silodosin, Placebo)

    Completed
    Has Results
    • Benign Prostatic Hyperplasia (BPH)
    • Huntsville, Alabama
    • +42 more
    Jul 5, 2011

    Benign Prostatic Hyperplasia (BPH) Trial in Kanto region (KSO-0400, Silodosin, Placebo)

    Completed
    • Benign Prostatic Hyperplasia (BPH)
    • Kanto region, Japan
      Japan
    Jun 30, 2011